Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model.

Clinical trial NCT05933525 · COMPLETED

Trial details

NCT number: NCT05933525
Sponsor: Immuron Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diarrhea Travelers Diarrhea Infectious Diarrhea

Start date: 2023-05-29
Primary completion: 2024-07-01
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.